Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking. 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
REDWOOD CITY, Calif., Sept. 06, 2016 -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at two upcoming investor conferences:
- The Rodman & Renshaw 18th Annual Global Investment Conference on Monday, September 12, 2016 at 12:05 PM ET at the Lotte New York Palace Hotel.
- The 2016 Aegis Capital Growth Conference on Wednesday, September 21, 2016 at 11:00 AM PT at the Wynn Las Vegas.
The presentations will be webcast live and may be accessed by visiting the “Events & Presentations” section of the Company's website at www.capnia.com. The webcasts will also be available on the Company’s website for a limited period of time following the conferences.
About Capnia
Capnia is a leading provider and developer of innovative healthcare products used for the screening, detection and treatment of medical conditions. Capnia’s flagship products, Serenz® Allergy Relief and CoSense® ETCO Monitor, are based on its proprietary technologies, which utilize precision metering of gas flow. Capnia currently markets Serenz Allergy Relief in the UK and Ireland. The CoSense ETCO Monitor, which measures end-tidal carbon monoxide (ETCO) that can be used to detect hemolysis, and the Infant Solutions product line, including innovative pulmonary resuscitation devices for neonates and infants, are marketed globally. Capnia is also clinically evaluating its nasal, non-inhaled CO2 technology to treat trigeminally-mediated pain conditions such as cluster headache and trigeminal neuralgia. For more information, please visit www.capnia.com.
Investor Relations Contact: Michelle Carroll/Susie Kim Argot Partners (212) 600-1902 [email protected] [email protected]
